Contribute Try STAT+ Today

WASHINGTON — Donald Trump has promised to change Washington, and he surely will. Yet while he may play some wild cards in the realms of medicine, science, and public health, you can also look for some surprising continuity with President Obama’s administration.

Here’s our preview of what to expect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • The statement that Trump’s pick to lead OMB does not support government-funded research was startling, and prompted me to look into the source. But I took away a very different conclusion after reading Mick Milvaney’s FB post on the subject, which is that he does not support government-funded research into Zika. This is still concerning, but the implications are vastly different than no support of government-funded research at all. The latter conclusion would only be drawn by reading that one sentence but not the rest of the post.

  • Notified today that my prescription drug was no longer getting any discount from the manufactor, my $50 copay disappeared. I was cringing at the prospect of a $500 charge for a 30 day script (price I had paid a year ago)… Then horror of horrors, the same prescription for a 30 day supply has increased an average of $1,200.00. To approximately $1,697.99, I am stunned! Most people can’t begin to pay this price for one script, let alone have other prescriptions. I also believe that under Trump prices will only increase. I am left speechless.

  • We need better pain management treatment! I don’t want opoiods…I want better pain management. I have had Fibromyalgia with peripheral neuropathy for almost 10 years. My pain management physician started me on opoiods and then took me off of them. I don’t want to take opoids…it first helped with my pain but by April 2016, it provided about 30% pain reduction. For other people, opoids provide better pain relief. If you don’t anyone to take opoiods, then WE NEED BETTER PAIN MANAGEMENT BECAUSE NOTHING ELSE IS EFFECTIVE FOR EVERYONE. CDC should have had a replacement available when releasing guidelines in 2016. The way CDC handled the pain epidemic was…they didn’t handle it. Suicides have occurred without being linked to CDC GUIDELINES 2016. please contact me with comments via email [email protected].

Comments are closed.